CYP2J2 is also upregulated in numerous forms of cancer [6] and has been detected in five human-derived malignant hematological cell lines, as well as in leukemia cells from peripheral blood and bone marrow in 86% of patients with malignant hematologic diseases [7,8]. The gene discussed is CYP2J2; the disease is cancer.